.svg)
The Texas Heart Institute Collaborates with Aviara Pharmaceuticals, Inc. to Develop Novel IBD Drug
HOUSTON (Sept. 26, 2023) — Aviara Pharmaceuticals, Inc., through a research collaboration with The Texas Heart Institute® (THI), recently was...
Ronald J Biediger
NIH Awards The Texas Heart Institute $1.14 Million to Develop a Novel, First-in-Class Drug for Atherosclerotic Cardiovascular Disease
HOUSTON (Aug. 22, 2023) — The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute® (THI)...
Texas Heart Institute Investigators Receive Grant Through NHLBI Catalyze Program
Texas Heart Institute (THI) Molecular Cardiology researchers Peter Vanderslice, PhD, and Ronald J. Biediger, PhD, were recently awarded a grant from...
Dr. Darren Woodside – Texas Heart Institute Vice President for Research – Receives Heralded Fellow Designation by the National Academy of Inventors
HOUSTON, TX (DECEMBER 7, 2021) – The Texas Heart Institute is pleased to announce that Dr. Darren G. Woodside, Senior...
Visionary THI Scientist Honored by the National Academies of Inventors
Ronald J. Biediger, Ph.D., a visionary scientist, and inventor, and a highly respected member of the Texas Heart Institute and the...
Technology Co-Invented by THI Scientists In the News
Technology co-invented by scientists at the Texas Heart Institute and 7 Hills Pharma received broad patent protection from the U.S....
Texas Heart Institute & 7 Hills Pharma awarded a $1.9 million grant from National Heart Lung Blood Institute to improve stem cell transplantation
HOUSTON, TX (June 11, 2020) —The Texas Heart Institute and 7 Hills Pharma (7 Hills) received a $1.9 million, Phase...
Texas Heart Institute’s molecular discovery at the heart of a new vaccine development program
A promising molecular technology co-invented by scientists at the Texas Heart Institute and 7 Hills could soon enhance the effectiveness...
Texas Heart Institute Discovery to Enhance the Immune System Moves Closer to Clinical Testing
A promising technology invented at the Texas Heart Institute is one step closer to being tested in a clinical study...
